Abbott (ABT) closed the most recent trading day at $118.48, moving -1.3% from the previous trading session. The stock's change was less than the S&P 500's daily loss of 1.02%. At the same time, the Dow lost 1.04%, and the tech-heavy Nasdaq lost 1.65%.The the stock of maker of infant formula, medical devices and drugs has risen by 7.51% in the past month, leading the Medical sector's gain of 4.07% and the S&P 500's gain of 3.64%.The investment community will be paying close attention to the earnings performa ...

Abbott (ABT) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.Over the past month, shares of this maker of infant formula, medical devices and drugs have returned +5.8%, compared to the Zacks S&P 500 composite's +4.8% change. During this period, the Zacks Medical - Products industry, which Abbott falls in, has gained 0.6%. The key question now is: What could be the stock's future direct ...

Anti-obesity drugs rose in popularity last year, helping the leaders in this market -- notably Eli Lilly and Novo Nordisk -- crush the market. However, some medical device specialists got the wrong end of the stick. That was the case with Abbott Laboratories (ABT -0.02%), whose diabetes care segment is perceived as its most important growth driver. Some investors thought GLP-1 medicines such as Ozempic could decrease demand for some of Abbott's key products.But that's not the case. Anti-obesity medicines wo ...

Nearing retirement can feel freeing. You've worked your entire career for this! Naturally, the stressful part of retiring is protecting your saved money. It's arguably more important to prevent steep losses than to continue building wealth.While no stock or investment is risk-free, you can find blue-chip stocks in industries like healthcare that will always be in demand because they're a pillar of modern society.Here are three fabulous healthcare stocks with ironclad financials. You can buy and hold these s ...

miodrag ignjatovic/E+ via Getty ImagesWe previously covered Abbott Laboratories (NYSE:NYSE:ABT) in October 2023 as a Buy, discussing Ozempic/Mounjaro as the driving force surrounding the increased adoption for ABT's glucose monitoring equipment, FreeStyle Libre. The same had been observed in the company's Diabetes Medical Devices and Nutrition segment performances over the past few quarters, further contributing to its profitable growth trend then. By now, it is apparent that ABT has exceeded expectatio ...

In the stock market, finding solid blue-chip stocks can lead to substantial portfolio growth. While the hype of flashy stocks often gets headlines, the steady performers driving constant returns truly boost portfolios. The article lists three such hidden gems. These blue-chip stocks operate in diverse sectors—consumer staples, pharmaceuticals and healthcare equipment. Each company has its own unique growth trajectory and market strategies.The first one, amidst macroeconomic challenges, holds resilience, lev ...

It has been about a month since the last earnings report for Abbott (ABT) . Shares have added about 5.8% in that time frame, outperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is Abbott due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important catalysts. Abbott Q4 Earnings Match Estimates, Margins ExpandAbbott ...

Investors in the vulnerable global economy constantly seek the Holy Grail: stocks immune to economic downturns. As the stock markets sway with economic and geopolitical uncertainty winds, finding those rare diamonds can feel like navigating a labyrinth blindfolded.However, seven solid companies weather the storm amidst the chaos and emerge stronger. Below are seven stocks of resilience, each a beacon of stability and growth in tumultuous times.Read more to delve into these corporations’ fundamentals, triump ...

In the latest trading session, Abbott (ABT) closed at $119.02, marking a +0.98% move from the previous day. The stock's change was less than the S&P 500's daily gain of 2.11%. Elsewhere, the Dow saw an upswing of 1.18%, while the tech-heavy Nasdaq appreciated by 2.96%.The the stock of maker of infant formula, medical devices and drugs has risen by 6.41% in the past month, leading the Medical sector's gain of 3.98% and the S&P 500's gain of 3.08%.The upcoming earnings release of Abbott will be of great inter ...

Abbott Laboratories reported strong earnings Wednesday, despite spending recent months responding to ... [+] criticism over problems that led to the shutdown of one of its infant formula-producing plants. (Stacey Wescott/Chicago Tribune/Tribune News Service via Getty Images)TNSAbbott (NYSE: ABT) reported its Q4 results last month, with revenues above and earnings aligning with the street estimates. The company reported revenue of $10.24 billion and earnings of $1.19 on a per-share and adjusted basis, compar ...